BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patel M, Eckburg A, Gantiwala S, Hart Z, Dein J, Lam K, Puri N. Resistance to Molecularly Targeted Therapies in Melanoma. Cancers (Basel) 2021;13:1115. [PMID: 33807778 DOI: 10.3390/cancers13051115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mao R, Yang F, Zhang T, Li J. Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma. Front Immunol 2021;12:756282. [PMID: 35003069 DOI: 10.3389/fimmu.2021.756282] [Reference Citation Analysis]
2 Senko C, Gunjur A, Balasubramanian A, Gan HK, Parakh S, Cher L. The systemic management of central nervous system metastases and leptomeningeal disease from advanced lung, melanoma, and breast cancer with molecular drivers: An Australian perspective. Asia Pac J Clin Oncol 2022. [PMID: 35238161 DOI: 10.1111/ajco.13759] [Reference Citation Analysis]
3 Tabolacci C, Cordella M, Rossi S, Bonaccio M, Eramo A, Mischiati C, Beninati S, Iacoviello L, Facchiano A, Facchiano F. Targeting Melanoma-Initiating Cells by Caffeine: In Silico and In Vitro Approaches. Molecules 2021;26:3619. [PMID: 34199192 DOI: 10.3390/molecules26123619] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Fromme JE, Zigrino P. The Role of Extracellular Matrix Remodeling in Skin Tumor Progression and Therapeutic Resistance. Front Mol Biosci 2022;9:864302. [DOI: 10.3389/fmolb.2022.864302] [Reference Citation Analysis]